Japanese postmarketing surveillance of clopidogrel in patients with non-ST-segment elevation acute coronary syndrome, stable angina, old myocardial infarction, and ST-segment elevation myocardial infarction after percutaneous coronary intervention in a real-life setting: the final report (J-PLACE Final)-Reference-Cited by-同舟云学术

Japanese postmarketing surveillance of clopidogrel in patients with non-ST-segment elevation acute coronary syndrome, stable angina, old myocardial infarction, and ST-segment elevation myocardial infarction after percutaneous coronary intervention in a real-life setting: the final report (J-PLACE Final)

Published:2015-10-08 Issue:2 Volume:31 Page:101-113
ISSN:1868-4300
Container-title:Cardiovascular Intervention and Therapeutics
language:en
Short-container-title:Cardiovasc Interv and Ther

Author:

Ako Junya,Morino Yoshihiro,Okuizumi Kaoru,Usami Makiko,Nakamura Masato

Funder

Sanofi (Japan)

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12928-015-0355-z.pdf

Reference19 articles.

1. Levine GN, Bates ER, Blankenship JC, Bailey SR, Bittl JA, Cercek B, et al. ACCF/AHA/SCAI guideline for Percutaneous Coronary Intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. Circulation. 2011;2011(124):e574–651.

2. Smith SC Jr, Benjamin EJ, Bonow RO, Braun LT, Creager MA, Franklin BA, et al. AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. J Am Coll Cardiol. 2011;58:2432–46.

3. Guideline for diagnosis and treatment of cardiovascular disease (2010). Guidelines for elective percutaneous coronary intervention in patients with stable coronary disease (JCS 2011).

4. Guideline for diagnosis and treatment of cardiovascular disease (2006–2007). Guidelines for the management of patients with ST-elevation myocardial infarction (JCS 2008).

5. Plavix® (clopidogrel sulfate tablet) package insert (ver. 15), revised Jan 2015. Sanofi K.K.

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between Systolic Pulmonary Artery Pressure and Contrast-Induced Nephropathy in Patients with ST-Segment Elevation Myocardial Infarction;ACTA CARDIOL SIN;2024

2. The usefulness of arylesterase in predicting contrast-induced nephropathy in ST-segment elevation myocardial infarction patients undergoing percutaneous coronary intervention;Journal of Health Sciences and Medicine;2023-03-27

3. Prognostic Factors and Outcomes in Young Patients With Presented of Different Types Acute Coronary Syndrome;Angiology;2020-07-09

4. Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis;Journal of Interventional Cardiology;2019-08-25

5. Towards Personalized Antithrombotic Treatments: Focus on P2Y12 Inhibitors and Direct Oral Anticoagulants;Clinical Pharmacokinetics;2019-06-27